Recent Finacing
Recent Raise
Capricor Therapeutics is a Los Angeles–based biotechnology company developing cardiac regenerative therapies including cardiosphere-derived cell product CAP-1002 and peptide candidate Cenderitide, advancing planned clinical trials for cardiac and Duchenne cardiomyopathy.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors